Cellebrite DI(CLBT)
$10.65-0.47 (-4.23%)
CLBT
Cellebrite DI financials statements
$10.65
At close:-0.47 (-4.23%)
Want to see CLBT full AI Analyst Report?
Cellebrite DI (CLBT) Ratios
605 Followers
Cellebrite DI Ratios
CLBT's free cash flow for Q3 2026 was $51.80M. For the 2026 fiscal year, CLBT's free cash flow was decreased by $-4.78M and operating cash flow was $56.58M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 |
| Quick Ratio | 1.54 | 1.89 | 1.62 | 1.38 | 1.43 |
| Cash Ratio | 0.34 | 0.65 | 0.75 | 0.42 | 0.78 |
| Solvency Ratio | 0.20 | -0.77 | -0.14 | 0.39 | 0.19 |
| Operating Cash Flow Ratio | 0.46 | 0.45 | 0.40 | 0.10 | 0.19 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 121.32M | $ 213.05M | $ -76.59M | $ -33.50M | $ -139.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.00 |
| Debt-to-Equity Ratio | 0.05 | 0.03 | 0.41 | 0.21 | 0.00 |
| Debt-to-Capital Ratio | 0.04 | 0.03 | 0.29 | 0.17 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.94 | 2.06 | 15.58 | 5.46 | -4.63 |
| Debt Service Coverage Ratio | 0.00 | -0.78 | 0.00 | 873.48 | 513.44 |
| Interest Coverage Ratio | 0.00 | 0.16 | 0.00 | 7.01 | 90.34 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.09 | 1.72 | 0.07 | 0.08 | 0.00 |
| Net Debt to EBITDA | -0.99 | 0.68 | 2.71 | -0.56 | -1.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.20% | 84.40% | 83.63% | 81.25% | 82.72% |
| EBIT Margin | 19.17% | -68.78% | -23.01% | 44.67% | 33.49% |
| EBITDA Margin | 21.67% | -66.14% | -19.93% | 48.07% | 36.33% |
| Operating Profit Margin | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% |
| Pretax Profit Margin | 19.06% | -68.79% | -23.24% | 44.62% | 33.42% |
| Net Profit Margin | 16.47% | -70.54% | -24.95% | 44.63% | 28.99% |
| Continuous Operations Profit Margin | 16.47% | -70.54% | -24.95% | 44.63% | 28.99% |
| Net Income Per EBT | 86.38% | 102.54% | 107.33% | 100.04% | 86.75% |
| EBT Per EBIT | 136.40% | -484.98% | -227.35% | 11567.05% | 595.46% |
| Return on Assets (ROA) | 8.34% | -40.98% | -15.22% | 29.95% | 21.01% |
| Return on Equity (ROE) | 16.17% | -84.22% | -237.05% | 163.55% | -97.34% |
| Return on Capital Employed (ROCE) | 11.68% | 14.40% | 11.91% | 0.53% | 9.02% |
| Return on Invested Capital (ROIC) | 10.02% | 14.26% | 11.19% | 0.52% | 7.83% |
| Return on Tangible Assets | 10.62% | -43.50% | -16.37% | 33.08% | 23.66% |
| Earnings Yield | 1.74% | -6.13% | -4.92% | 15.17% | 6.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.53 | 4.87 | 4.21 | 3.44 | 3.65 |
| Payables Turnover | 4.47 | 5.65 | 6.43 | 11.00 | 4.46 |
| Inventory Turnover | 9.89 | 7.00 | 5.36 | 4.99 | 6.54 |
| Fixed Asset Turnover | 12.35 | 14.54 | 10.78 | 8.22 | 14.70 |
| Asset Turnover | 0.51 | 0.58 | 0.61 | 0.67 | 0.72 |
| Working Capital Turnover Ratio | 1.99 | 1.82 | 2.54 | 3.10 | 1.96 |
| Cash Conversion Cycle | 35.73 | 62.46 | 98.12 | 146.24 | 74.03 |
| Days of Sales Outstanding | 80.55 | 74.93 | 86.75 | 106.22 | 100.06 |
| Days of Inventory Outstanding | 36.92 | 52.13 | 68.16 | 73.19 | 55.84 |
| Days of Payables Outstanding | 81.74 | 64.59 | 56.79 | 33.17 | 81.87 |
| Operating Cycle | 117.46 | 127.05 | 154.91 | 179.41 | 155.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.68 | 0.63 | 0.54 | 0.11 | 0.25 |
| Free Cash Flow Per Share | 0.62 | 0.58 | 0.50 | 0.06 | 0.19 |
| Dividend Paid and CapEx Coverage Ratio | 12.78 | 12.46 | 12.89 | 2.26 | 0.33 |
| Capital Expenditure Coverage Ratio | 12.78 | 12.46 | 12.89 | 2.26 | 4.44 |
| Operating Cash Flow Coverage Ratio | 7.45 | 12.05 | 7.22 | 1.34 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.36 | 0.33 | 0.31 | 0.08 | 0.15 |
| Free Cash Flow Yield | 3.46% | 2.63% | 5.72% | 1.44% | 2.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 58.16 | -16.31 | -20.31 | 6.59 | 16.18 |
| Price-to-Sales (P/S) Ratio | 9.47 | 11.50 | 5.07 | 2.94 | 4.69 |
| Price-to-Book (P/B) Ratio | 9.30 | 13.73 | 48.13 | 10.78 | -15.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 28.93 | 37.96 | 17.49 | 69.31 | 41.33 |
| Price-to-Operating Cash Flow Ratio | 26.67 | 34.91 | 16.14 | 38.71 | 32.03 |
| Price-to-Earnings Growth (PEG) Ratio | -0.47 | -0.08 | 0.12 | 0.24 | 0.01 |
| Enterprise Value Multiple | 42.73 | -16.71 | -22.71 | 5.57 | 11.28 |
| Enterprise Value | 4.40B | 4.43B | 1.47B | 724.25M | 1.01B |
| EV to EBITDA | 42.73 | -16.71 | -22.71 | 5.57 | 11.28 |
| EV to Sales | 9.26 | 11.05 | 4.53 | 2.68 | 4.10 |
| EV to Free Cash Flow | 28.28 | 36.48 | 15.63 | 63.02 | 36.11 |
| EV to Operating Cash Flow | 26.07 | 33.55 | 14.42 | 35.20 | 27.99 |
| Tangible Book Value Per Share | 1.13 | 1.41 | -0.02 | 0.20 | -0.77 |
| Shareholders’ Equity Per Share | 1.94 | 1.60 | 0.18 | 0.40 | -0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | -0.03 | -0.07 | -0.00 | 0.13 |
| Revenue Per Share | 1.90 | 1.92 | 1.71 | 1.48 | 1.71 |
| Net Income Per Share | 0.31 | -1.35 | -0.43 | 0.66 | 0.50 |
| Tax Burden | 0.86 | 1.03 | 1.07 | 1.00 | 0.87 |
| Interest Burden | 0.99 | 1.00 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.24 | 0.25 | 0.26 | 0.30 | 0.27 |
| SG&A to Revenue | 0.46 | 0.46 | 0.13 | 0.15 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.08 | 0.06 | 0.05 | 0.03 |
| Income Quality | 2.16 | -0.47 | -1.26 | 0.17 | 0.50 |
Currency in USD

